The score is not available for this stock. This could be because (a) the market cap of the... Read More
Value score
The score is not available for this stock. This could be because (a) the market cap of the... Read More
Price Momentum score
The score is not available for this stock. This could be because (a) the market cap of the... Read More
QVM score
The score is not available for this stock. This could be because (a) the market cap of the... Read More
NORRIS Key Metrics
NORRIS Share Price
Stock Analysis
Snapshot
Shareholding Pattern
Bulk, Block & Insider Trades
Corporate Actions
Company Profile
NORRIS Share Price
NORRIS
1 Week returns: -
1 Month returns: -
1 Year returns: -
3 Years CAGR: -
5 Years CAGR: -
Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
NORRIS Stock Analysis
Views
Red Flags
Positive
Strong revenue growth and above median growth of industry
Negative
Stock is fairly expensive with negative EPS on a trailing 12-month basis
Low and declining operating margin
Low EPS growth and lower than median growth of industry
Low dividend yield
Neutral
Not enough talking point with neutral stance
Stock in GSM list
The stock has been places in Graded Surveillance Measure (GSM) list (GSM - 0).
Thinly traded (low daily turnover)
The stock is thinly traded with combined (NSE & BSE) daily turnover (21-day average) of 0.00236807.
Snapshot
See detailed analysis
NORRIS Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
NORRIS Bulk, Block & Insider Trades
NORRIS Dividends, Splits & Bonus
Dividend Events
Capital Change Events
No dividend events found
Others
Capital Reduction (CRD)The existing paid up capital has been reduced by 70 percent as a result every 10 equity shares has been consolidated into 3 equity shares. Ex-date: 22nd Aug 2013 Announced on: 20th Aug 2013
Company Profile
Norris Medicines Limited is an India-based company, which is focused on the health care industry. The Company is engaged in the manufacturing and exporting medicines and injections. The Company’s product categories include antibiotic, anti-inflammatory and analgesic range, G. I. range, dermatologica... Read More
Key personnel
Mr. Iqubal Patel
Chief Financial Officer
Mr. Vimal Dhirendra ShahD
Executive Director, Managing Director
Ms. Priyanka Lohiya
Company Secretary
Mr. Praveen J. BafnaD
Non-Executive Director
Mr. Angamuthu VadivelD
Non-Executive Independent Director
Sathya VenkatachalamD
Non-Executive Independent Director
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Norris Medicines Ltd.?
The current share price of Norris Medicines Ltd. is ₹ 15.00 as of 09 Jan 2026.
What is the PE ratio of Norris Medicines Ltd.?
The Price-to-Earnings (PE) ratio of Norris Medicines Ltd. is - as of the latest financial data.
What is the ROE and ROCE of Norris Medicines Ltd.?
Norris Medicines Ltd. has a Return on Equity (ROE) of - and a Return on Capital Employed (ROCE) of -13.70% as per the latest financial reports.
What is the market cap of Norris Medicines Ltd.?
The market capitalization of Norris Medicines Ltd. stands at ₹ 15.00 Cr.
What is the dividend yield of Norris Medicines Ltd.?
The dividend yield of Norris Medicines Ltd. is 0.00% based on the current market price.
What is the RSI of Norris Medicines Ltd.?
The Relative Strength Index (RSI) of Norris Medicines Ltd. is 42.83.
What is the FII and DII holding in Norris Medicines Ltd.?
Foreign Institutional Investors (FII) hold 0.00% and Domestic Institutional Investors (DII) hold 0.07% of Norris Medicines Ltd. shares.
What sector does Norris Medicines Ltd. belong to?
Norris Medicines Ltd. operates in the Services sector.
What is the beta of Norris Medicines Ltd. stock?
The beta of Norris Medicines Ltd. stock is 0.22, indicating its volatility relative to the broader market.